Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-05-21

Clinical Trial Update: Doxorubicin Plus Estramustine in Treating Patients With Metastatic Prostate Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial assessing the safety and preliminary activity of doxorubicin plus estramustine in patients with metastatic prostate cancer; the study status is co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Doxorubicin (doxorubicin)
  • Estramustine (estramustine)

Snippet

Sponsor: University of New Mexico | Conditions: Prostate Cancer | Phase 1 | Status: COMPLETED